FindTrial
Sign In

Factors affecting tyrosine kinase inhibitors response in chronic myeloid leukemia patients

Factors affecting tyrosine kinase inhibitors response in chronic myeloid leukemia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180703001
Enrollment
100
Registered
2018-07-03
Start date
2018-07-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Despite the excellent efficacy obtained for the treatment of CML&#44

Interventions

Thai patients with chronic myeloid leukemia who taking tyrosine kinase inhibitors
Basic Science
Thai patients with chronic myeloid leukemia

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: •Thai patients with chronic myeloid leukemia received tyrosine kinase inhibitors for at least 6 months in Srinagarind Hospital. •The patients are at least 18 years of age. •The patients are willing to participate in the study and signed a consent form.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Drug response Within 3 months after the patients took tyrosine kinase inhibitors Lab results—

Secondary

MeasureTime frame
Adverse drug reactions Within 3 months after the patients took tyrosine kinase inhibitors Medical record review, interview—

Countries

Thailand

Contacts

Public ContactNitsupa Wattanachai

Faculty of Medicine, Khon Kaen University

nitsu_wat@yahoo.com043348397

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026